A dose interval study of vendolizumab in patients with inflammatory bowel disease
Latest Information Update: 24 Nov 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 24 Nov 2018 New trial record